OxySure Therapeutics, Inc. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2014)

$2.4M

Net Income/Loss (FY2014)

-$2.8M

Total Assets (FY2014)

$2.5M

Total Equity (FY2014)

$1.1M

Cash Flows from Operating Activities (FY2014)

-$1.1M

Source: OxySure Therapeutics, Inc. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.